Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.28
-0.21 (-2.80%)
Dec 27, 2024, 4:00 PM EST - Market closed
Lifecore Biomedical Market Cap
Lifecore Biomedical has a market cap or net worth of $268.10 million as of December 27, 2024. Its market cap has increased by 53.46% in one year.
Market Cap
268.10M
Enterprise Value
399.44M
1-Year Change
53.46%
Ranking
Category
Stock Price
$7.28
Market Cap Chart
Since December 1, 1998, Lifecore Biomedical's market cap has increased from $51.30M to $268.10M, an increase of 422.61%. That is a compound annual growth rate of 6.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 26, 2024 | 231.40M | 23.28% |
Dec 29, 2023 | 187.70M | -2.14% |
Dec 30, 2022 | 191.80M | -41.35% |
Dec 31, 2021 | 327.00M | 3.06% |
Dec 31, 2020 | 317.30M | -3.76% |
Dec 31, 2019 | 329.70M | 0.33% |
Dec 31, 2018 | 328.60M | -5.19% |
Dec 29, 2017 | 346.60M | -7.79% |
Dec 30, 2016 | 375.90M | 17.62% |
Dec 31, 2015 | 319.60M | -13.85% |
Dec 31, 2014 | 371.00M | 15.58% |
Dec 31, 2013 | 321.00M | 31.29% |
Dec 31, 2012 | 244.50M | 70.98% |
Dec 30, 2011 | 143.00M | -9.55% |
Dec 31, 2010 | 158.10M | -3.89% |
Dec 31, 2009 | 164.50M | -4.47% |
Dec 31, 2008 | 172.20M | -50.66% |
Dec 31, 2007 | 349.00M | 29.79% |
Dec 29, 2006 | 268.90M | 42.50% |
Dec 30, 2005 | 188.70M | 18.75% |
Dec 31, 2004 | 158.90M | 13.58% |
Dec 31, 2003 | 139.90M | 261.50% |
Dec 31, 2002 | 38.70M | -36.87% |
Dec 31, 2001 | 61.30M | 35.92% |
Dec 29, 2000 | 45.10M | -54.90% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
aTyr Pharma | 287.08M |
Candel Therapeutics | 285.78M |
Senseonics Holdings | 283.26M |
Aldeyra Therapeutics | 283.16M |
Vanda Pharmaceuticals | 281.63M |
Procaps Group | 279.80M |
Foghorn Therapeutics | 279.08M |
COMPASS Pathways | 275.74M |